| Chronic cardio-metabolic disorders | T2DM | CKD | CVD | ||||
---|---|---|---|---|---|---|---|---|
Validation | Developed | Validation | Developed | Validation | Developed | Validation | Developed | |
Men (N = 1310) | ||||||||
 Number of events at score category | 261 | 166 | 102 | 68 | 173 | 120 | 59 | 37 |
 Number of high-risk populations | 575 | 286 | 575 | 286 | 575 | 286 | 575 | 286 |
 Sensitivity, % | 63.8 | 42.9 | 57.4 | 40.2 | 72.7 | 52.6 | 79.4 | 50.7 |
 Specificity, % | 70.9 | 87 | 63.3 | 80.9 | 67.6 | 84.7 | 63 | 79.9 |
Women (N = 1960) | ||||||||
 Number of events at score category | 646 | 329 | 189 | 85 | 542 | 304 | 49 | 32 |
 Number of high-risk populations | 992 | 408 | 992 | 408 | 992 | 408 | 992 | 408 |
 Sensitivity, % | 66.7 | 35.4 | 75.3 | 35.6 | 66.8 | 38.7 | 95.9 | 65.3 |
 Specificity, % | 70.0 | 92.3 | 56.5 | 81.2 | 65.6 | 91.1 | 53.8 | 80.3 |